

Author: Zi Dan Zhou Zhi-Wei Yang Ying-Jie Huang Lin Zhou Zun-Lun He Shu-Ming He Zhi-Xu Zhou Shu-Feng
Publisher: MDPI
E-ISSN: 1422-0067|16|11|27228-27251
ISSN: 1422-0067
Source: International Journal of Molecular Sciences, Vol.16, Iss.11, 2015-11, pp. : 27228-27251
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Ovarian carcinoma (OC) is one of the most common gynecological malignancies, with a poor prognosis for patients at advanced stage. Danusertib (Danu) is a pan-inhibitor of the Aurora kinases with unclear anticancer effect and underlying mechanisms in OC treatment. This study aimed to examine the cancer cell killing effect and explore the possible mechanisms with a focus on proliferation, cell cycle progression, apoptosis, autophagy, and epithelial to mesenchymal transition (EMT) in human OC cell lines C13 and A2780cp. The results showed that Danu remarkably inhibited cell proliferation, induced apoptosis and autophagy, and suppressed EMT in both cell lines. Danu arrested cells in G2/M phase and led to an accumulation of polyploidy through the regulation of the expression key cell cycle modulators. Danu induced mitochondria-dependent apoptosis and autophagy in dose and time-dependent manners. Danu suppressed PI3K/Akt/mTOR signaling pathway, evident from the marked reduction in the phosphorylation of PI3K/Akt/mTOR, contributing to the autophagy inducing effect of Danu in both cell lines. In addition, Danu inhibited EMT. In aggregate, Danu exerts potent inducing effect on cell cycle arrest, apoptosis, and autophagy, but exhibits a marked inhibitory effect on EMT. PI3K/Akt/mTOR signaling pathway contributes, partially, to the cancer cell killing effect of Danu in C13 and A2780cp cells.
Related content


By Lin Yu-Tsai Wang Hung-Chen Hsu Yi-Chiang Cho Chung-Lung Yang Ming-Yu Chien Chih-Yen
International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-06 ,pp. :


By Guo Chuan-Long Wang Li-Jun Zhao Yue Liu Hua Li Xiang-Qian Jiang Bo Luo Jiao Guo Shu-Ju Wu Ning Shi Da-Yong
Marine Drugs, Vol. 16, Iss. 2, 2018-01 ,pp. :


By Kim Kwang-Youn Park Kwang-Il Kim Sang-Hun Yu Sun-Nyoung Park Sul-Gi Kim Young Woo Seo Young-Kyo Ma Jin-Yeul Ahn Soon-Cheol
International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-05 ,pp. :

